This talk will review the molecular genetics and clinical components of diagnosing and caring for children and adults with SMA.We will review the natural history of the disease and how the clear understanding of disease etiology has allowed 2 new FDA therapies to change the landscape of this once deadly disorder.
Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.
Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.